» Articles » PMID: 30588425

Intracameral Lidocaine As Supplement to Classic Topical Anesthesia for Relieving Ocular Pain in Cataract Surgery

Overview
Specialty Ophthalmology
Date 2018 Dec 28
PMID 30588425
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To evaluate safety, efficacy, and patient adherence of intracameral lidocaine as supplement of classic topical anesthetic drops in cataract surgery.

Methods: A prospective and controlled trial including a large cohort of 1650 individuals suffering with bilateral cataract not complicated, in program by phacoemulsification surgery, were randomly assigned to 2 different groups for the type of anesthesia received, 0.4% oxybuprocaine hydrochloride (INN) drops, and INN drops associated to intracameral 1% lidocaine hydrochloride monohydrate. At the end of surgery, tables were assigned to each patient indicating the degree of pain (0-3) felt during the operation.

Results: Thirty-two percent of patients in group 1 declared to have not felt any pain against the 77% of patients in group 2. Fifty-nine percent of patients in group 1 complained about only a slight discomfort against 20% of group 2 patients. Only a small percentage of patients in group 1 (5%) admitted severe pain, while no patient in group 2 admitted severe pain. Four patients of group 2 reported an episode of transient amaurosis, lasting several hours after surgery.

Conclusion: Intracameral administration of lidocaine is a simple and secure method able to increase the analgesia during the cataract surgery, eliminating the discomfort and increasing also the cooperation of the patients during the steps of manipulation.

Citing Articles

Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms.

Gugleva V, Andonova V Pharmaceuticals (Basel). 2023; 16(3).

PMID: 36986574 PMC: 10058782. DOI: 10.3390/ph16030474.


Globe penetration during loco-regional anesthesia: prevalence and review of cases.

Gomez-Benlloch A, Olivera M, Nadal J, Julio G, Elizalde J Int J Ophthalmol. 2022; 15(10):1683-1690.

PMID: 36262846 PMC: 9522552. DOI: 10.18240/ijo.2022.10.18.


Efficacy and safety of intraoperative use of tropicamide 0.02%/phenylephrine0.31%/lidocaine1% intracameral combination during pediatric cataract surgery.

Nucci P, Lembo A, Caputo R, Dellavalle A, Serafino M, Schiavetti I Int Ophthalmol. 2022; 43(3):989-995.

PMID: 36053475 DOI: 10.1007/s10792-022-02501-4.


Topical anaesthesia plus intracameral lidocaine versus topical anaesthesia alone for phacoemulsification cataract surgery in adults.

Minakaran N, Ezra D, Allan B Cochrane Database Syst Rev. 2022; 7:CD005276.

PMID: 35658539 PMC: 8190979. DOI: 10.1002/14651858.CD005276.pub4.


Use of Simultaneous Bilateral Cataract Surgery (SBCS) to Optimize Parameters Affecting the Subjective Perception of the Procedure.

Studeny P, Vranova J, Novacek L J Ophthalmol. 2021; 2021:5584906.

PMID: 34194819 PMC: 8214475. DOI: 10.1155/2021/5584906.

References
1.
Wirbelauer C, Iven H, Bastian C, Laqua H . Systemic levels of lidocaine after intracameral injection during cataract surgery. J Cataract Refract Surg. 1999; 25(5):648-51. DOI: 10.1016/s0886-3350(99)00005-x. View

2.
Anders N, Heuermann T, Ruther K, Hartmann C . Clinical and electrophysiologic results after intracameral lidocaine 1% anesthesia: a prospective randomized study. Ophthalmology. 1999; 106(10):1863-8. DOI: 10.1016/S0161-6420(99)90394-9. View

3.
Macky T, Werner L, Apple D, Izak A, Pandey S, Trivedi R . Viscoanesthesia. Part II: toxicity to intraocular structures after phacoemulsification in a rabbit model. J Cataract Refract Surg. 2003; 29(3):556-62. DOI: 10.1016/s0886-3350(02)01603-6. View

4.
Catterall W, Cestele S, Yarov-Yarovoy V, Yu F, Konoki K, Scheuer T . Voltage-gated ion channels and gating modifier toxins. Toxicon. 2007; 49(2):124-41. DOI: 10.1016/j.toxicon.2006.09.022. View

5.
Ezra D, Nambiar A, Allan B . Supplementary intracameral lidocaine for phacoemulsification under topical anesthesia. A meta-analysis of randomized controlled trials. Ophthalmology. 2007; 115(3):455-87. DOI: 10.1016/j.ophtha.2007.09.021. View